These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37841023)

  • 1. Nasal Absorption Enhancement of Mometasone Furoate Nanocrystal Dispersions.
    Masuda S; Deguchi S; Ogata F; Yoshitomi J; Otake H; Kanai K; Kawasaki N; Nagai N
    Int J Nanomedicine; 2023; 18():5685-5699. PubMed ID: 37841023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis.
    Altuntaş E; Yener G
    AAPS PharmSciTech; 2017 Oct; 18(7):2673-2682. PubMed ID: 28281209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intranasal mometasone in the fixed-dose combination GSP301 versus two monotherapy intranasal mometasone formulations.
    Patel P; Salapatek AM; Talluri RS; Tantry SK
    Allergy Asthma Proc; 2018 May; 39(3):232-239. PubMed ID: 29669668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a Thermosensitive In Situ Gel Containing Mometasone Furoate on a Rat Allergic Rhinitis Model.
    Altuntaş E; Yener G; Doğan R; Aksoy F; Şerif Aydın M; Karataş E
    Am J Rhinol Allergy; 2018 May; 32(3):132-138. PubMed ID: 29644886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a combination of mometasone furoate, levofloxacin, and retinyl palmitate with an in situ gel-forming nasal delivery system on nasal mucosa damage repair in an experimental rabbit model.
    Aksoy F; Dogan R; Ozturan O; Altuntas E; Yener FG; Topcu G; Guler B
    Biomed Pharmacother; 2017 Dec; 96():603-611. PubMed ID: 29035825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps.
    Kern RC; Stolovitzky JP; Silvers SL; Singh A; Lee JT; Yen DM; Iloreta AMC; Langford FPJ; Karanfilov B; Matheny KE; Stambaugh JW; Gawlicka AK;
    Int Forum Allergy Rhinol; 2018 Apr; 8(4):471-481. PubMed ID: 29350840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zein nanoparticles as oral carrier for mometasone furoate delivery.
    Zimath P; Pinto S; Dias S; Rafacho A; Sarmento B
    Drug Deliv Transl Res; 2023 Nov; 13(11):2948-2959. PubMed ID: 37208563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of cytokine release by fluticasone furoate vs. mometasone furoate in human nasal tissue ex-vivo.
    Zhang N; Van Crombruggen K; Holtappels G; Lan F; Katotomichelakis M; Zhang L; Högger P; Bachert C
    PLoS One; 2014; 9(4):e93754. PubMed ID: 24710117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
    Daley-Yates PT; Deans A; Mehta R; Sousa AR
    Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate leukocyte infiltration in the lower turbinate mucosa after a two-week intranasal administration of mometasone furoate, azelastine or salmon calcitonin.
    Vera-Cruz P; Ferreira M; Zagalo C; dos Santos MJ; Aguas AP
    Rev Laryngol Otol Rhinol (Bord); 2009; 130(2):105-9. PubMed ID: 19813472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
    Kosoglou T; Hubbell J; Xuan F; Cutler DL; Meehan AG; Kantesaria B; Wittmer BA
    Int J Chron Obstruct Pulmon Dis; 2013; 8():107-16. PubMed ID: 23525511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Release and Pharmacokinetic Evaluation of Novel Implantable Mometasone Furoate Matrices in Rabbit Maxillary Sinuses.
    You C; Tseng LF; Pappas A; Concagh D; Kuang Y
    Am J Rhinol Allergy; 2022 Mar; 36(2):198-206. PubMed ID: 34463546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mometasone furoate intranasal spray is effective in reducing symptoms and adenoid size in children and adolescents with adenoid hypertrophy.
    Ghafar MHA; Mohamed H; Mohammad NMY; Mohammad ZW; Madiadipoera T; Wang Y; Abdullah B
    Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(3):147-153. PubMed ID: 31400807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery.
    Liu S; Watts AB; Du J; Bui A; Hengsawas S; Peters JI; Williams RO
    Eur J Pharm Biopharm; 2015 Oct; 96():132-42. PubMed ID: 26220015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate.
    Cao SL; Ren XW; Zhang QZ; Chen E; Xu F; Chen J; Liu LC; Jiang XG
    Int J Pharm; 2009 Jan; 365(1-2):109-15. PubMed ID: 18822361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mometasone furoate-loaded aspasomal gel for topical treatment of psoriasis: formulation, optimization,
    Shinde G; Desai P; Shelke S; Patel R; Bangale G; Kulkarni D
    J Dermatolog Treat; 2022 Mar; 33(2):885-896. PubMed ID: 32603203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis.
    Minshall E; Ghaffar O; Cameron L; O'Brien F; Quinn H; Rowe-Jones J; Davies RJ; Prior A; Lund VJ; Mackay IS; Nolop K; Lutsky B; Durham SR; Hamid Q
    Otolaryngol Head Neck Surg; 1998 May; 118(5):648-54. PubMed ID: 9591864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mometasone absorption in cultured airway epithelium.
    Nguyen TT; Soma PS; Mascenik T; Lewis CA; Lee RE; Thorp BD; Zanation AM; Ebert CS; Senior BA; Randell SH; Ehrmann BM; Kimple AJ
    Int Forum Allergy Rhinol; 2019 Dec; 9(12):1451-1455. PubMed ID: 31633879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
    Kaur N; Sharma K; Bedi N
    Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical observation of mometasone furoate nasal spray combined with montelukast sodium in the treatment of adenoid hypertrophy in children].
    Liu W; Chen RJ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):366-368. PubMed ID: 29871263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.